Based on the previous findings, the significant downregulation of ALDOA was assumed to lead to the reduction of aldolase A, which is an important regulator of glycolysis, which could lead to neurological abnormalities in patients with AD [36]. Here, ALDOA is linked to Alzheimer disease.